Endpoint · BiomarkerActive studySynthetic mock data
ctDNA clearance (MRD-)
P2-CRC-D0918
Type
Biomarker
Target
≥ 60% by week 16
Current
47%
Status
At riskVendor delay on Q2 panel
Definition
BiomarkerctDNA clearance (MRD-)
Applies to P2-CRC-D0918; target ≥ 60% by week 16.
Progress to threshold78%
Events met — by arm
Cohort A — MRD+
30 / 64 needed
Cases contributing to this endpoint
2 contributing records
| Case | Arm | Visit | Contribution | Date |
|---|---|---|---|---|
| D0918-CRC-014 | MRD+ | Wk 12 | ctDNA undetectable | 2026-04-24 |
| D0918-CRC-031 | MRD+ | Wk 16 | ctDNA undetectable | 2026-04-19 |
Related endpoints